Durham startup Dualogics sells platform for producing therapeutic antibodies
Durham-based Dualogics has sold its core technology for producing therapeutic antibodies to a Canadian biotechnology company. Here are the details.
Read More
dualogics
Durham immunotherapy firm Dualogics, South Korea biotech partner to target cancer
Durham immunotherapy company Dualogics has entered into a collaboration agreement with South Korea’s Y-Biologics to use their combined expertise to discover and develop novel cancer antibodies.
Read More
